AASOX | NRGSX | AASOX / NRGSX | |
Total Expense Ratio | 1.00 | 0.74 | 135% |
Annual Report Gross Expense Ratio | 1.00 | 0.74 | 135% |
Fund Existence | 37 years | 13 years | - |
Gain YTD | 2.134 | -2.862 | -75% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 500000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 145M | 8.89B | 2% |
Annual Yield % from dividends | 0.38 | 0.06 | 607% |
Returns for 1 year | 1.30 | -6.97 | -19% |
Returns for 3 years | 7.00 | 12.34 | 57% |
Returns for 5 years | -53.02 | 7.76 | -683% |
Returns for 10 years | -32.95 | 17.91 | -184% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PJP | 91.08 | 0.87 | +0.96% |
Invesco Pharmaceuticals ETF | |||
RDTE | 33.39 | 0.28 | +0.85% |
Roundhill Russell 2000 0DTECovCllStgyETF | |||
TDVG | 43.71 | 0.27 | +0.63% |
T. Rowe Price Dividend Growth ETF | |||
NUAG | 21.27 | 0.02 | +0.12% |
Nuveen Enhanced Yield US Aggt Bd ETF | |||
KDRN | 23.27 | N/A | N/A |
Kingsbarn Tactical Bond ETF |